Article
Amyloid Beta and MicroRNAs in Alzheimer’s Disease
3 May 2019
Abstract excerpt
Alzheimer's disease (AD) is a progressive mental illness characterized by memory loss and multiple cognitive impairments. In the last several decades, significant progress has been made in understanding basic biology, molecular mechanisms, and development of biomarkers and therapeutic drugs. Multiple cellular changes are implicated in the disease process including amyloid beta and phosphorylation of tau synaptic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
